Cyclosporine vs. tacrolimus immunosuppression does not effect plasma homocysteine levels in cardiac transplant recipients

被引：0
|
作者：
Testani, JM
Aranda, JM
Pauly, DF
Hill, JA
Schofield, RS
机构：
[1] Univ Florida, Div Cardiovasc Med, Gainesville, FL USA
[2] Dept Vet Affairs Med Ctr, Cardiol Sect, Gainesville, FL USA
来源：
JOURNAL OF CARDIAC FAILURE | 2004年 / 10卷 / 04期
关键词：
D O I：
10.1016/j.cardfail.2004.06.192
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
193
引用
收藏
页码：S70 / S70
页数：1
相关论文
共 50 条
  • [1] Incidence of Cytomegalovirus Infection Among Liver Transplant Recipients Maintained on a Cyclosporine vs. Tacrolimus-Based Immunosuppression Regimen
    Burrelli, C.
    Bradley, M.
    Pouch, S.
    Elkhammas, E.
    Winters, H.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 505 - 506
  • [2] No differences in plasma homocysteine (Hcy) levels between cyclosporine (CsA)- or tacrolimus (TAC)- treated renal transplant recipients (RTR)
    Bae, J
    Tolkoff-Rubin, NE
    Baid, S
    Ovuworie, CA
    Williams, WW
    Shih, VE
    Cosimi, AB
    Pascual, MA
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 372A - 372A
  • [3] Tacrolimus, cyclosporine and plasma lipoproteins in renal transplant recipients
    Venkiteswaran, K
    Sgoutas, DS
    Santanam, N
    Neylan, JE
    [J]. TRANSPLANT INTERNATIONAL, 2001, 14 (06) : 405 - 410
  • [4] Cardiac hypertrophy in liver transplant recipients: Tacrolimus, cyclosporine or both?
    Therapondos, G
    Plevris, JN
    Dollinger, MM
    Hayes, PC
    Flapan, AD
    [J]. TRANSPLANTATION, 2003, 76 (02) : 446 - 447
  • [5] Conversion from cyclosporine to tacrolimus based immunosuppression therapy in renal transplant recipients
    Backman, Lars
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 51 (04) : A33 - A33
  • [6] Conversion from cyclosporine to tacrolimus based immunosuppression thrapy in renal transplant recipients
    Backman, Lars A.
    [J]. TRANSPLANT INTERNATIONAL, 2007, 20 : 138 - 138
  • [7] A randomized trial of tacrolimus vs Neoral cyclosporine in heart transplant recipients
    Kobashigawa, JA
    Moriguchi, JD
    Chuang, JM
    Wener, L
    Yeatman, L
    Ro, T
    Devereaux, D
    Kawata, N
    Laks, H
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 222A - 222A
  • [8] Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients -: A large European trial
    Grimm, M
    Rinaldi, M
    Yonan, NA
    Arpesella, G
    Del Prado, JMA
    Pulpén, LA
    Villemot, JP
    Frigerio, M
    Lambert, JLR
    Crespo-Leiro, MG
    Almenar, L
    Duveau, D
    Ordonez-Fernandez, A
    Gandjbakhch, J
    Maccherini, M
    Laufer, G
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (06) : 1387 - 1397
  • [9] Malignancies in de novo renal transplant recipients using branded cyclosporine microemulsion (BCSA) vs. tacrolimus
    Legorreta, Antonio P.
    Robinson, Matthew L.
    Gilmore, Amanda S.
    Ryskina, Kira L.
    Naujoks, Christel
    [J]. TRANSPLANT INTERNATIONAL, 2007, 20 : 136 - 136
  • [10] THE DETERMINANTS OF ELEVATED TOTAL PLASMA-CHOLESTEROL LEVELS IN CARDIAC TRANSPLANT RECIPIENTS ADMINISTERED LOW-DOSE CYCLOSPORINE FOR IMMUNOSUPPRESSION
    LAUFER, G
    GRABLOWITZ, V
    LACZKOVICS, A
    MIHOLIC, J
    HEINZ, G
    WOLLENEK, G
    SCHREINER, W
    WOLFRAM, J
    WOLNER, E
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1992, 104 (02): : 241 - 247
12345